Us Advisors Wealth Management, LLC Lineage Cell Therapeutics, Inc. Transaction History

Us Advisors Wealth Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.13 - $1.77 $12,281 - $19,238	10,869 New	10,869 $12,000
Q2 2022 Aug 12, 2022	SELL	$1.12 - $1.61 $12,173 - $17,499	-10,869 Closed	0 $0
Q1 2022 Jun 08, 2022	BUY	$1.21 - $2.48 $13,151 - $26,955	10,869 New	10,869 $17,000

120

94.2M

63.8K

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $84.9M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

Get notified when there are updates to the investment portfolio of Us Advisors Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Us Advisors Wealth Management, LLC with notifications on news.